𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Maternal use of bupropion and risk for congenital heart defects

✍ Scribed by Sura Alwan; Jennita Reefhuis; Lorenzo D. Botto; Sonja A. Rasmussen; Adolfo Correa; Jan M. Friedman


Book ID
113436409
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
234 KB
Volume
203
Category
Article
ISSN
1097-6868

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Maternal asthma, asthma medication use,
✍ Shao Lin; Michele Herdt-Losavio; Lenore Gensburg; Elizabeth Marshall; Charlotte πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 2 views

## Abstract **BACKGROUND:** Asthma is a common problem that complicates pregnancy. Several drugs are considered acceptable for use during pregnancy, although none have been classified as safe. Few studies have assessed the health impact of maternal asthma/medication use on the fetus. **METHODS:** A

Maternal periconceptional alcohol consum
✍ Suzan L. Carmichael; Gary M. Shaw; Wei Yang; Edward J. Lammer πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 2 views

## Abstract ## BACKGROUND In this study we investigated whether the risk of delivering infants with conotruncal heart defects was increased among mothers who consumed alcohol during the periconceptional period (i.e., 1 month before conception to 3 months after conception). ## METHODS Data were o

Maternal corticosteroid use and risk of
✍ Carmichael, Suzan L.; Shaw, Gary M. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 11 KB πŸ‘ 2 views

Evidence for the teratogenicity of corticosteroids in humans is limited and has resulted in inconsistent recommendations regarding their use during early pregnancy. We examined the association between women's corticosteroid use during the periconceptional period (1 month before to 3 months after con